Abstract:Background: Immune system dysfunction has been proven to be an important pathological event in Alzheimer's disease (AD). Mild cognitive impairment (MCI), as a transitional stage between normal cognitive function and AD, was an important research object for the screening of early diagnostic markers and therapeutic targets for AD. However, systematic assessment of peripheral immune system changes in MCI patients and consistent analysis with that in the CNS were still lacking. Methods: Peripheral blood transcriptome data from the AddNeuroMed Cohort (n = 711) was used as a training dataset to assess the abundance of 24 immune cells through ImmuCellAI and to identify MCI-related immune signaling pathways and hub genes. The expression level of the immune hub gene was validated in peripheral blood (n = 587) and brain tissue (78 entorhinal cortex, 140 hippocampi, 91 temporal cortex, and 232 frontal cortex) validation datasets. Finally, reliable immune hub genes were applied for Gene Set Enrichment Analysis and correlation analysis of AD pathological characteristics. Results: MCI patients have early changes in the abundance of various types of immune cells in peripheral blood, accompanied by significant changes in NF-kB, TNF, JAK-STAT, and MAPK signaling pathways. Five hub immune-related differentially expressed genes (NFKBIA, CD4, RELA, CASP3, and HSP90AA1) were screened by the cytoHubba plugin in Cytoscape and the least absolute shrinkage and selection operator (LASSO) regression. Their expression levels were significantly correlated with infiltration score and the abundance of monocytes, natural killer cells, Th2 T cells, T follicular helper cells, and cytotoxic T cells. After validation with independent datasets derived from peripheral blood and brain, RELA and HSP90AA1 were identified as two reliable immune hub genes in MCI patients and had consistent changes in AD. The Gene Set Enrichment Analysis (GSEA) showed that their expression levels were closely associated with Alzheimer's disease, JAK-STAT, calcium signaling pathway, etc. In addition, the expression level of RELA was positively correlated with β- and γ-secretase activity and Braak stage. The expression level of HSP90AA1 was negatively correlated with α- and β-secretase activity. Conclusion: Immune system dysfunction was an early event in AD. It provides a new target for the early diagnosis and treatment of AD.

Cellular Transcriptional Alterations of Peripheral Blood in Alzheimer's Disease.

Single-Cell RNA Sequencing of Peripheral Blood Reveals Immune Cell Signatures in Alzheimer’s Disease

Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis

Peripheral Immune Cells Contribute to the Pathogenesis of Alzheimer's Disease

Immune abnormalities and differential gene expression in the hippocampus and peripheral blood of patients with Alzheimer’s disease

Characterization of peripheral immune cell populations in stable and progressive Alzheimer’s disease

Single-Nucleus Landscape of Glial Cells and Neurons in Alzheimer's Disease

Increased monocyte activity identified in Alzheimer’s disease by in depth single‐cell genomic and proteomic analysis

Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification

Identification of altered immune cell types and molecular mechanisms in Alzheimer's disease progression by single-cell RNA sequencing

Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease

Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline

Identification of molecular alterations in leukocytes from gene expression profiles of peripheral whole blood of Alzheimer’s disease

Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

Computational analysis of peripheral blood RNA sequencing data unravels disrupted immune patterns in Alzheimer's disease

Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients

Exploring the links among peripheral immunity, biomarkers, cognition, and neuroimaging in Alzheimer's disease

Single Cell Transcriptome Analysis Identified a Unique Neutrophil Type Associated with Alzheimer’s Disease

Epigenetic dysregulation in Alzheimer’s disease peripheral immunity

[Identification of Peripheral Blood GZMK + CD8 + T Cells As Biomarkers of Alzheimer's Disease Based on Single-Cell Transcriptome]

Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology